Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-02-25 @ 8:31 PM
Study NCT ID:
NCT03700359
Status:
UNKNOWN
Last Update Posted:
2019-11-29
First Post:
2018-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC
Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ES-SCLC 001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None